⌘K

Home/Filings/4/0000081362-24-000138

4//SEC Filing

Bijlani Jeewat 4

Accession 0000081362-24-000138

CIK 0000081362other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:17 PM ET

Size

9.0 KB

Accession

0000081362-24-000138

Insider Transaction Report

Form 4

Period: 2024-11-22

QUAKER CHEMICAL CORPKWR

EVP, Chief Strategy Officer

Transactions

Exercise/Conversion
Common Stock
2024-11-22$154.92/sh+645$99,923→ 5,392 total
Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-22−645→ 0 total
Exercise: $154.92Exp: 2025-02-26→ Common Stock (645 underlying)
Sale
Common Stock
2024-11-22$165.98/sh−645$107,057→ 4,747 total

Holdings

Common Stock
(indirect: By 401(k))
60

Footnotes (2)

[F1]Information based on reporting person's Plan Statement as of September 30, 2024.
[F2]The options for this grant vested in three annual installments: 807 shares on August 15, 2019; 807 shares on February 26, 2020; and 807 shares on February 26, 2021.

Documents

1 file

4
wk-form4_1732655850.xmlPrimary
FORM 4

Issuer

QUAKER CHEMICAL CORP

CIK 0000081362

Entity typeother

Related Parties

1

filerCIK 0001783821

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 4:17 PM ET
Size: 9.0 KB

View on SEC.gov